Ipamorelin vs Tesamorelin
A GHRP versus a GHRH analogue. Here is how the two research peptides compare on class, format and price.
Ipamorelin
Ipamorelin is a synthetic selective growth-hormone-releasing peptide (GHRP). It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.
Ipamorelin is studied for selective ghrelin/GHS-receptor activity and is commonly researched together with the GHRH analogue CJC-1295.
Tesamorelin
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.
Tesamorelin is studied for GHRH-receptor signalling in metabolic and growth-hormone research, and sits alongside CJC-1295 in the GHRH-analogue class.
Which do researchers choose?
Ipamorelin and Tesamorelin are a GHRP versus a GHRH analogue. The right choice depends on the research question: they differ in class (Selective GHRP vs GHRH analogue) and strength (10 mg vs 10 mg). Both are supplied lyophilised, third-party HPLC tested, and shipped express post Australia-wide for laboratory and in-vitro research use only.
Frequently asked questions
What is the difference between Ipamorelin and Tesamorelin?
Ipamorelin is Selective GHRP; Tesamorelin is GHRH analogue. A GHRP versus a GHRH analogue.
Are Ipamorelin and Tesamorelin for human use?
No. Both are supplied strictly for laboratory and in-vitro research use, not for human or veterinary consumption.